IDL Biotech AB (XSAT:IDL) EV-to-EBIT : -13.93 (As of May. 24, 2024)

IDL Biotech AB EV-to-EBIT Chart

IDL Biotech AB Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EV-to-EBIT		Get a 7-Day Free Trial					56.66	195.86	-37.90	-56.19	-7.67

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
EV-to-EBIT	Get a 7-Day Free Trial															-26.37	-15.03	-7.67	-7.37	-13.97

Competitive Comparison of IDL Biotech AB's EV-to-EBIT

For the Diagnostics & Research subindustry, IDL Biotech AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDL Biotech AB's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's EV-to-EBIT falls into.

IDL Biotech AB EV-to-EBIT Calculation

IDL Biotech AB's EV-to-EBIT for today is calculated as:

IDL Biotech AB's current Enterprise Value is kr178.50 Mil.
IDL Biotech AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-12.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Biotech AB  (XSAT:IDL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

IDL Biotech AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2021 is calculated as:

IDL Biotech AB's Enterprise Value for the quarter that ended in Jun. 2021 was kr179.13 Mil.
IDL Biotech AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-12.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Biotech AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description